The interaction between Lyn and FcεμRIβ is indispensable for FcεμRI-mediated human mast cell activation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 10, 2012, Pages 1241-1249

  Okayama, Y ^a   Kashiwakura, J I ^a   Matsuda, A ^b   Sasaki Sakamoto, T ^a   Nunomura, S ^a   Yokoi, N ^c   Ebihara, N ^b   Kuroda, K ^a   Ohmori, K ^a   Saito, H ^d   Ra, C ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Fc RI ; histamine; human mast cells; immunoreceptor tyrosine based activation motif; Lyn

Indexed keywords

FC EPSILON RECEPTOR; FC EPSILON RECEPTOR BETA SUBUNIT; FC RECEPTOR; IMMUNOGLOBULIN E; PROTEIN KINASE LYN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL DEGRANULATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SENSITIZATION; SIGNAL TRANSDUCTION;

ADULT; CELL DEGRANULATION; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MAST CELLS; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84866441382     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02879.x.     Document Type: Article

References (18)

1. Metzger H,. The receptor with high affinity for IgE. Immunol Rev 1992; 125: 37-48.
2. Kinet JP,. The high-affinity IgE receptor (FcεμRI): from physiology to pathology. Annu Rev Immunol 1999; 17: 931-972.
3. Gilfillan AM, Tkaczyk C,. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006; 6: 218-230. (Pubitemid 43290991)
4. Matsuda A, Okayama Y, Ebihara N, Yokoi N, Hamuro J, Walls AF, et al. Hyperexpression of the high-affinity IgE receptor-β chain in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci 2009; 50: 2871-2877.
5. Lin S, Cicala C, Scharenberg AM, Kinet JP,. The FcεμRIβ subunit functions as an amplifier of FcεμRIγ-mediated cell activation signals. Cell 1996; 85: 985-995. (Pubitemid 26231166)
6. Dombrowicz D, Lin S, Flamand V, Brini AT, Koller BH, Kinet JP,. Allergy-associated FcRβ is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 1998; 8: 517-529. (Pubitemid 28196805)
7. Donnadieu E, Jouvin MH, Kinet JP,. A second amplifier function for the allergy-associated FcεμRI-β subunit. Immunity 2000; 12: 515-523.
8. Pribluda VS, Pribluda C, Metzger H,. Biochemical evidence that the phosphorylated tyrosines, serines, and threonines on the aggregated high affinity receptor for IgE are in the immunoreceptor tyrosine-based activation motifs. J Biol Chem 1997; 272: 11185-11192. (Pubitemid 27184114)
9. Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, et al. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεμRI. Blood 2003; 102: 2547-2554. (Pubitemid 37193594)
10. Kimura I, Moritani Y, Tanizaki Y,. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 1973; 3: 195-202.
11. Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC,. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266: 3239-3245. (Pubitemid 21909200)
12. Nishida K, Yamasaki S, Ito Y, Kabu K, Hattori K, Tezuka T, et al. FcεμRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol 2005; 170: 115-126. (Pubitemid 40994101)
13. Kovarova M, Tolar P, Arudchandran R, Draberova L, Rivera J, Draber P,. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcεμ receptor I aggregation. Mol Cell Biol 2001; 21: 8318-8328. (Pubitemid 33108592)
14. Jo D, Liu D, Yao S, Collins RD, Hawiger J,. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 2005; 11: 892-898. (Pubitemid 41161123)
15. Furumoto Y, Nunomura S, Terada T, Rivera J, Ra C,. The FcεμRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IκB kinase phosphorylation and mast cell cytokine production. J Biol Chem 2004; 279: 49177-49187. (Pubitemid 39625801)
16. Yamashita Y, Charles N, Furumoto Y, Odom S, Yamashita T, Gilfillan AM, et al. Cutting edge: genetic variation influences FcεμRI-induced mast cell activation and allergic responses. J Immunol 2007; 179: 740-743.
17. Alvarez-Errico D, Yamashita Y, Suzuki R, Odom S, Furumoto Y, Yamashita T, et al. Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in FcεμRI-dependent mast cell activation. J Immunol 2010; 184: 5000-5008.
18. Xiao W, Nishimoto H, Hong H, Kitaura J, Nunomura S, Maeda-Yamamoto M, et al. Positive and negative regulation of mast cell activation by Lyn via the FcεμRI. J Immunol 2005; 175: 6885-6892. (Pubitemid 41598934)